Drug Profile
Research programme: metastatic breast cancer therapy - Chugai
Alternative Names: CH 4893237Latest Information Update: 22 Jul 2010
Price :
$50
*
At a glance
- Originator Chugai Biopharmaceuticals; Immusol
- Developer Chugai Biopharmaceuticals; iTherX Pharmaceuticals
- Class Estradiol congeners
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer metastases